Yan-Ting Shiu1, Silvio H Litovsky2, Alfred K Cheung3, Daniel B Pike1, Jason Chieh Sheng Tey1, Yingying Zhang4, Carlton J Young5, Michelle Robbin6, Kenneth Hoyt7, Michael Allon8. 1. Divisions of Nephrology and Hypertension, and. 2. Departments of Pathology. 3. Divisions of Nephrology and Hypertension, and Renal Section, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah; Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; and. 4. Epidemiology, University of Utah, Salt Lake City, Utah. 5. Surgery, and. 6. Radiology, and. 7. Department of Bioengineering, University of Texas at Dallas, Dallas, Texas. 8. Division of Nephrology University of Alabama at Birmingham, Birmingham, Alabama; mdallon@uab.edu.
Abstract
BACKGROUND AND OBJECTIVES: Arteriovenous fistula maturation requires an increase in the diameter and blood flow of the feeding artery and the draining vein after its creation. The structural properties of the native vessels may affect the magnitude of these changes. We hypothesized that an increase in the collagen content of the vascular media (medial fibrosis) preoperatively would impair vascular dilation and thereby, limit the postoperative increase in arteriovenous fistula diameter and blood flow and clinical arteriovenous fistula maturation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We enrolled 125 patients undergoing arteriovenous fistula creation between October of 2008 and April of 2012 and followed them prospectively. Any consenting subject was eligible. Arterial and venous specimens were sampled during arteriovenous fistula surgery. Masson's trichrome-stained samples were used to quantify medial fibrosis. Arteriovenous fistula diameter and blood flow were quantified using 6-week postoperative ultrasound. Clinical arteriovenous fistula maturation was assessed using a predefined protocol. The association of preexisting vascular medial fibrosis with arteriovenous fistula outcomes was evaluated after controlling for baseline demographics, comorbidities, and the preoperative venous diameter. RESULTS: The mean medial fibrosis was 69%±14% in the arteries and 63%±12% in the veins. Arterial medial fibrosis was associated with greater increases in arteriovenous fistula diameter (Δdiameter =0.58 mm; 95% confidence interval [95% CI], 0.27 to 0.89 mm; P<0.001) and arteriovenous fistula blood flow (Δblood flow =85 ml/min; 95% CI, 19 to 150 ml/min; P=0.01) and a lower risk of clinical arteriovenous fistula nonmaturation (odds ratio, 0.71; 95% CI, 0.51 to 0.99; P=0.04), all per 10% absolute difference in medial fibrosis. In contrast, venous medial fibrosis was not associated with the postoperative arteriovenous fistula diameter, blood flow, or clinical maturation. CONCLUSIONS: Preoperative arterial medial fibrosis was associated with greater arteriovenous fistula diameter and blood flow and a lower risk of clinical arteriovenous fistula nonmaturation. This unexpected observation suggests that medial fibrosis promotes arteriovenous fistula development by yet undefined mechanisms or alternatively, that a third factor promotes both medial fibrosis and arteriovenous fistula maturation.
BACKGROUND AND OBJECTIVES:Arteriovenous fistula maturation requires an increase in the diameter and blood flow of the feeding artery and the draining vein after its creation. The structural properties of the native vessels may affect the magnitude of these changes. We hypothesized that an increase in the collagen content of the vascular media (medial fibrosis) preoperatively would impair vascular dilation and thereby, limit the postoperative increase in arteriovenous fistula diameter and blood flow and clinical arteriovenous fistula maturation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We enrolled 125 patients undergoing arteriovenous fistula creation between October of 2008 and April of 2012 and followed them prospectively. Any consenting subject was eligible. Arterial and venous specimens were sampled during arteriovenous fistula surgery. Masson's trichrome-stained samples were used to quantify medial fibrosis. Arteriovenous fistula diameter and blood flow were quantified using 6-week postoperative ultrasound. Clinical arteriovenous fistula maturation was assessed using a predefined protocol. The association of preexisting vascular medial fibrosis with arteriovenous fistula outcomes was evaluated after controlling for baseline demographics, comorbidities, and the preoperative venous diameter. RESULTS: The mean medial fibrosis was 69%±14% in the arteries and 63%±12% in the veins. Arterial medial fibrosis was associated with greater increases in arteriovenous fistula diameter (Δdiameter =0.58 mm; 95% confidence interval [95% CI], 0.27 to 0.89 mm; P<0.001) and arteriovenous fistula blood flow (Δblood flow =85 ml/min; 95% CI, 19 to 150 ml/min; P=0.01) and a lower risk of clinical arteriovenous fistula nonmaturation (odds ratio, 0.71; 95% CI, 0.51 to 0.99; P=0.04), all per 10% absolute difference in medial fibrosis. In contrast, venous medial fibrosis was not associated with the postoperative arteriovenous fistula diameter, blood flow, or clinical maturation. CONCLUSIONS: Preoperative arterial medial fibrosis was associated with greater arteriovenous fistula diameter and blood flow and a lower risk of clinical arteriovenous fistula nonmaturation. This unexpected observation suggests that medial fibrosis promotes arteriovenous fistula development by yet undefined mechanisms or alternatively, that a third factor promotes both medial fibrosis and arteriovenous fistula maturation.
Authors: Michael Allon; Tom Greene; Laura M Dember; Joseph A Vita; Alfred K Cheung; Naomi M Hamburg; Peter B Imrey; James S Kaufman; Michelle L Robbin; Yan-Ting Shiu; Christi M Terry; Heidi R Umphrey; Harold I Feldman Journal: J Am Soc Nephrol Date: 2016-05-09 Impact factor: 10.121
Authors: T Ichii; H Koyama; S Tanaka; S Kim; A Shioi; Y Okuno; E W Raines; H Iwao; S Otani; Y Nishizawa Journal: Circ Res Date: 2001-03-16 Impact factor: 17.367
Authors: Michael Allon; Silvio Litovsky; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Michelle L Robbin Journal: Am J Kidney Dis Date: 2011-06-30 Impact factor: 8.860
Authors: Jan H N Lindeman; Brian A Ashcroft; Jan-Willem M Beenakker; Maarten van Es; Nico B R Koekkoek; Frans A Prins; Jarl F Tielemans; Hazem Abdul-Hussien; Ruud A Bank; Tjerk H Oosterkamp Journal: Proc Natl Acad Sci U S A Date: 2009-12-28 Impact factor: 11.205
Authors: Michael Allon; Silvio H Litovsky; Yingying Zhang; Ha Le; Alfred K Cheung; Yan-Ting Shiu Journal: Clin J Am Soc Nephrol Date: 2018-08-23 Impact factor: 8.237
Authors: Laisel Martinez; Juan C Duque; Marwan Tabbara; Angela Paez; Guillermo Selman; Diana R Hernandez; Chad A Sundberg; Jason Chieh Sheng Tey; Yan-Ting Shiu; Alfred K Cheung; Michael Allon; Omaida C Velazquez; Loay H Salman; Roberto I Vazquez-Padron Journal: J Am Soc Nephrol Date: 2018-01-02 Impact factor: 10.121
Authors: Daniel Pike; Yan-Ting Shiu; Yun-Fang Cho; Ha Le; Maheshika Somarathna; Tatyana Isayeva; Lingling Guo; J David Symons; Christopher G Kevil; John Totenhagen; Timmy Lee Journal: Sci Rep Date: 2019-03-12 Impact factor: 4.996
Authors: Michael Allon; Silvio H Litovsky; Jason Chieh Sheng Tey; Chad A Sundberg; Yingying Zhang; Zhen Chen; Yun Fang; Alfred K Cheung; Yan-Ting Shiu Journal: J Vasc Access Date: 2018-05-09 Impact factor: 2.283